Transfusion Treatment in Patients With SCD
National Transfusion Treatment Survey in Patients With Sickle Cell Disease (SCD)
Sponsor: Associazione Italiana de Ematologia e Oncologia Pediatrica
This observational or N/A phase trial investigates Anemia, Sickle Cell and is currently completed. Associazione Italiana de Ematologia e Oncologia Pediatrica leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2023 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Jun 2022 — May 2023 [monthly]
Recruiting
Status: Enrolling By Invitation → Recruiting
-
Jan 2021 — Jun 2022 [monthly]
Enrolling By Invitation
▶ Show 5 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Enrolling By Invitation
-
May 2019 — Nov 2020 [monthly]
Enrolling By Invitation
Status: Active Not Recruiting → Enrolling By Invitation
-
Jun 2018 — May 2019 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
First recorded
Jul 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Associazione Italiana de Ematologia e Oncologia Pediatrica
- Società Italiana Talassemie ed Emoglobinopatie
- Società Italiana di Medicina Trasfusionale e Immunoematologia
For direct contact, visit the study record on ClinicalTrials.gov .